Influence for Nonprofit Leaders

por Friedman, Deborah
Publicado 2013

Risk of Respiratory Syncytial Virus Hospitalization in the First and Second Years of Life in Pediatric Patients with Congenital Heart Disease

por Friedman, Deborah, Wong, Pierre C.
Publicado 2017

Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine

por Friedman, Deborah I., Cohen, Joshua M.
Publicado 2020

Unilateral pupillary mydriasis from nebulized ipratropium bromide: A false sign of brain herniation in the intensive care unit

por Chaudhry, Priyanka, Friedman, Deborah I., Yu, Wengui
Publicado 2014

Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report

por Weingarten, Sarah J., Friedman, Deborah, Arora, Anubha
Publicado 2020

Development and evaluation of an internet-based cognitive behavioral therapy intervention for anxiety and depression in adults with cystic fibrosis (eHealth CF-CBT): An internation...

por Verkleij, Marieke, Georgiopoulos, Anna M., Friedman, Deborah
Publicado 2021

To Be or Not to Be Treated: That Is the Question in Managing a Fetus With Cardiac Injury Exposed to Anti‐SSA/Ro

por Buyon, Jill, Saxena, Amit, Friedman, Deborah, Izmirly, Peter
Publicado 2022

Linking anti-Ro antibodies to fibrosis in congenital heart block: translation to a clinical trial

por Buyon, Jill P, Izmirly, Peter, Friedman, Deborah, Copel, Joshua
Publicado 2014

The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review

por Ailani, Jessica, Nahas, Stephanie J., Friedman, Deborah I., Kunkel, Todd
Publicado 2023

Brachial Artery Vasospasm From Sequential Use of Intravenous Promethazine and Dihydroergotamine for Treatment of Status Migrainosus: A Case Report

por Johns, Christopher, Ardakani, Rumyar, Das, Rohit R., Friedman, Deborah I., Frolov, Alexander
Publicado 2023

Improving to Four or Fewer Monthly Headache Days Per Month Provides a Clinically Meaningful Therapeutic Target for Patients with Chronic Migraine

por Kaniecki, Robert G., Friedman, Deborah I., Asher, Divya, Hirman, Joe, Cady, Roger
Publicado 2023

Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses

por Friedman, Deborah, Fryzek, Jon, Jiang, Xiaohui, Bloomfield, Adam, Ambrose, Christopher S., Wong, Pierre C.
Publicado 2017

Unexpected Etiology in a Case of Bilateral Maculopathy

por Patel, Prem, Jones, Kaylie, Friedman, Deborah I., Birch, David G., Ufret-Vincenty, Rafael L.
Publicado 2021

Patient engagement in the development of CF-CBT: A cystic fibrosis-specific cognitive-behavioral intervention for adults

por Friedman, Deborah, Kaskas, Maysa M., Quittner, Alexandra L., Smith, Beth A., Georgiopoulos, Anna M.
Publicado 2022

Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management

por Mollan, Susan P, Ali, Fizzah, Hassan-Smith, Ghaniah, Botfield, Hannah, Friedman, Deborah I, Sinclair, Alexandra J
Publicado 2016

Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study

por Detke, Holland C., Goadsby, Peter J., Wang, Shufang, Friedman, Deborah I., Selzler, Katherine J., Aurora, Sheena K.
Publicado 2018

Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients

por Nycz, Bryan T., Dominguez, Samuel R., Friedman, Deborah, Hilden, Joanne M., Ir, Diana, Robertson, Charles E., Frank, Daniel N.
Publicado 2018

Correction: Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients

por Nycz, Bryan T., Dominguez, Samuel R., Friedman, Deborah, Hilden, Joanne M., Ir, Diana, Robertson, Charles E., Frank, Daniel N.
Publicado 2018

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post‐Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial

por Dodick, David W., Tepper, Stewart J., Friedman, Deborah I., Gelfand, Amy A., Kellerman, Donald J., Schmidt, Peter C.
Publicado 2018

Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine

por Nahas, Stephanie J., Hindiyeh, Nada, Friedman, Deborah I., Elbuluk, Nada, Kellerman, Donald J., Foreman, Pamela K., Schmidt, Peter
Publicado 2021